Insiders · TENX

Declan Doogan

Director at Tenax Therapeutics, Inc. (TENX) since February 2021

Declan Doogan has filed 15 insider reports with the SEC since May 2021, as director at Tenax Therapeutics, Inc. (TENX) and director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). In the last 12 months Declan Doogan bought $102K of stock on the open market. In the latest filing, on September 18, 2026, Declan Doogan bought 53,000 shares of Tenax Therapeutics, Inc. (TENX) for $102K at an average of $1.92.

Filings
15
Companies
2
Bought on market
$102K
Sold on market
$13.3M

Companies where Declan Doogan is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Tenax Therapeutics, Inc. logo
TENX
Tenax Therapeutics, Inc.
Directorsince February 202155,274$102K$1.92$1.42-26%Sep 18, 2026
Biohaven Pharmaceutical Holding Co Ltd. logo
BHVN
Biohaven Pharmaceutical Holding Co Ltd.
Director0$13.3M$13.24Feb 12, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Declan Doogan with

Other insiders at the same companies

Questions about Declan Doogan

What is Declan Doogan's role at Tenax Therapeutics, Inc.?
Declan Doogan reports to the SEC as director at Tenax Therapeutics, Inc. (TENX), according to the latest filing on September 18, 2026. Declan Doogan has also filed as director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN).
How many shares does Declan Doogan own?
After the latest filing that states it, Declan Doogan directly owned 55,274 shares of Tenax Therapeutics, Inc. (TENX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Declan Doogan bought or sold stock recently?
The most recent open-market purchase was on September 16, 2026: bought 53,000 shares of Tenax Therapeutics, Inc. (TENX) for $102K at an average of $1.92. The most recent open-market sale was on June 16, 2020: sold 41,306 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN) for $2.83M at an average of $68.49.
How do I get alerts when Declan Doogan files?
Follow Declan Doogan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Declan Doogan filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Declan Doogan (SEC CIK 0001704234). Totals count each trade once, skipping amendments whose original is on file, from May 7, 2021 on. View on SEC EDGAR